Orca Investment Management’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-118,638
Closed -$3.18M 76
2017
Q4
$3.18M Sell
118,638
-2,260
-2% -$57.5K 2.78% 9
2017
Q3
$2.91M Sell
120,898
-4,606
-4% -$104K 2.58% 8
2017
Q2
$2.69M Sell
125,504
-1,962
-2% -$39.6K 2.51% 10
2017
Q1
$2.19M Sell
127,466
-580
-0.5% -$10.1K 1.99% 16
2016
Q4
$2.3M Buy
128,046
+24,964
+24% +$453K 2.24% 15
2016
Q3
$2.14M Buy
103,082
+43,932
+74% +$1.09M 2.23% 16
2016
Q2
$1.59M Sell
59,150
-404
-0.7% -$11.1K 1.56% 26
2016
Q1
$1.61M Sell
59,554
-372
-0.6% -$9.97K 1.82% 21
2015
Q4
$1.74M Buy
+59,926
New +$1.66M 1.92% 20

Other funds holding NVO

Orca Investment Management's NVO Position: Q1 2018 in Review

Orca Investment Management sold out of Novo Nordisk (NVO) in Q1 2018, closing a stake of 118,638 shares — an estimated $3.18M sold.

Orca Investment Management first reported a position in NVO in Q4 2015 and held it in 9 quarters. The position peaked at $3.18M in Q4 2017. 553 funds tracked by Wall St. Rank hold NVO as of Q1 2018.

  • Orca Investment Management reported no remaining Novo Nordisk position as of Q1 2018 after selling out during the quarter.
  • Orca Investment Management sold 118,638 Novo Nordisk shares in Q1 2018, an estimated $3.18M.
  • Orca Investment Management first reported a position in Novo Nordisk in Q4 2015 and held it in 9 quarters.
  • Orca Investment Management's Novo Nordisk position peaked at $3.18M in Q4 2017.
  • 553 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2018.

Based on Orca Investment Management's 13F filing for Q1 2018, filed 30 Apr 2018.